These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 19637355)

  • 1. Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature.
    Kaseb AO; Hanbali A; Cotant M; Hassan MM; Wollner I; Philip PA
    Cancer; 2009 Nov; 115(21):4895-906. PubMed ID: 19637355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.
    Pang R; Poon RT
    Cancer Lett; 2006 Oct; 242(2):151-67. PubMed ID: 16564617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular changes in hepatocellular carcinoma.
    Yang ZF; Poon RT
    Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
    Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
    J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of the expression of VEGF and KDR on the angiogenesis, growth and metastasis of hepatocellular carcinoma].
    Zhao A; Dou K; Li K; Fu Y
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):453-6. PubMed ID: 11832083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategy of antiangiogenic therapy for hepatocellular carcinoma.
    Wu XZ
    Neoplasma; 2008; 55(6):472-81. PubMed ID: 18999874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and anti-angiogenesis in hepatocellular carcinoma.
    Ribatti D; Vacca A; Nico B; Sansonno D; Dammacco F
    Cancer Treat Rev; 2006 Oct; 32(6):437-44. PubMed ID: 16870349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience.
    Montella L; Addeo R; Caraglia M; Faiola V; Guarrasi R; Vincenzi B; Palmeri A; Capasso E; Nocera V; Tarantino L; Ariete M; Martorelli A; Del Prete S
    Oncol Rep; 2008 Aug; 20(2):385-90. PubMed ID: 18636202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular density and VEGF expression in hepatic lesions.
    Brodsky SV; Mendelev N; Melamed M; Ramaswamy G
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical assessment of angiogenesis in primary hepatocellular carcinoma.
    Săftoiu A; Ciurea T; Baniţă M; Georgescu C; Comănescu V; Rogoveanu I; Gorunescu F; Georgescu I
    Rom J Gastroenterol; 2004 Mar; 13(1):3-8. PubMed ID: 15054519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting vessels to treat hepatocellular carcinoma.
    Romanque P; Piguet AC; Dufour JF
    Clin Sci (Lond); 2008 Apr; 114(7):467-77. PubMed ID: 18302534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic strategies in hepatocellular carcinoma: current status.
    Zacharoulis D; Hatzitheofilou C; Athanasiou E; Zacharoulis S
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):645-56. PubMed ID: 16111465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
    Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
    Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific molecular markers in hepatocellular carcinoma.
    Yao DF; Dong ZZ; Yao M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):241-7. PubMed ID: 17548245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
    Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein.
    Corradini SG; Morini S; Liguori F; Carotti S; Muda AO; Burza MA; Siciliano M; Molinaro A; Cantafora A; Blotta I; Merli M; Berloco P; Rossi M; Attili AF; Gaudio E
    Liver Int; 2009 Jan; 29(1):103-12. PubMed ID: 18544126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of vascular endothelial growth factor in kidney and prostate cancer.
    Delongchamps NB; Peyromaure M
    Can J Urol; 2007 Oct; 14(5):3669-77. PubMed ID: 17949520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.